great post. totally agree, and i'll check out that news
great post. totally agree, and i'll check out that news segment. the whole topic of MABs not being embraced sooner is incredibly frustrating. I watched my dad almost die from COVID - can't imagine those who have lost loved ones and the anger they feel knowing there was a therapeutic that could've saved their family member's life.
i was worried before the Brazil trials got started - that somehow the US FDA had strong-armed them into not following through. But now that it's rolling (and now that MABs are getting the respect they deserve) it's only a matter of time. You can suppress the truth for awhile, but eventually it will see the light of day - and that moment is approaching for us.
I would love to say that the FDA will face the fire for what they did with regard to our drug. But i'm sure they'll dodge any responsibility. no matter - we'll have our day in the sun soon enough - as soon as Brazil data materializes.
3
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Main Street Capital's Evolving Private Loan Portfolio Main Street Capital Corporation (NYSE: MAIN) has made remarkable strides in developing its private loan portfolio. During the fourth quarter of the year, Main Street recorded a significant increase in new loan commitments amounting to $123.4 million, alongside investments totaling $108.0 million across its portfolio....
Continue Reading
Enhancing Customer Experiences Together Reality Based Group, known for its innovative approach to improving customer experiences, is making waves in the food service industry through a new partnership with Dave's Hot Chicken. This fast-growing chain, popular for its delicious menu offerings, has recognized the value of enhancing its customer service via advanced...
Continue Reading
Jumping right in, JMIR Publications is making waves in the academic world with its latest Journal Impact Factor (JIF) triumphs. If these folks were publicly traded, you'd want a piece because they are dominating the digital health research scene like no other. Emphasizing their stronghold, 12 out of their 24 journals clinched top-quartile spots this year—a feat that's...
Continue Reading
21shares Unveils New Canton Network ETP 21shares, a prominent issuer of cryptocurrency exchange-traded products (ETPs), has made waves in the financial markets with the introduction of the 21shares Canton Network ETP (CANTN). This innovative offering enables investors to gain exposure to the Canton Coin, the native utility token within the Canton Network, an initiative...
Continue Reading
The stock market experienced mixed results recently as investors zeroed in on critical economic indicators and job reports. Amidst ongoing geopolitical tensions, particularly in the Middle East, traders were navigating through uncertainty that impacted their portfolios. Major Indices Performances: Diverging Paths The S&P 500 dropped by 0.2%, while the Dow Jones Industrial...
Continue Reading